Review Commons, a pre-journal portable review platform
Multi-journal partnership aims to accelerate scientific publishing by offering journal-independent peer review
DetailsMulti-journal partnership aims to accelerate scientific publishing by offering journal-independent peer review
DetailsNine life scientists join the new EMBO Programme in its first year
DetailsMALT1 blockers have long been in clinical use for the treatment of blood cancers. A study suggests that these drugs could potentially also be developed as a treatment option for glioblastoma, the most common and lethal type of brain tumour.
DetailsEMBO Press is pleased to announce the appointment of systems biologist M. Madan Babu as the new Chief Editor of Molecular Systems Biology.
DetailsThe annual EMBO Members’ Meeting took place from 29-31 October 2019 in Heidelberg, Germany, and welcomed 53 recently elected members, who presented their work in talks and were able to meet each other and find out more about EMBO.
DetailsEMBO congratulates twenty-seven life scientists on their selection as new EMBO Young Investigators.
DetailsEMBO and EMBO Press are making their journals’ finances public to provide transparency and clarity about what it costs to publish articles in high quality, selective journals.
DetailsThe Israeli Acute Paralysis Virus is a pathogen that affects honey bees and has been linked to Colony Collapse Disorder, a key factor in decimating the bee population.
DetailsThere are many indications that fasting promotes longevity. In recent years, much attention has been devoted to so-called caloric restriction mimetics (CMRs), substances that simulate the health-promoting effects of fasting without the need of life-style change.
DetailsSalaried employment, contributions to social security schemes, leadership training and networking
Details